This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Stivarga
  • /
  • Regorafenib Monotherapy as Second-line Treatment o...
Clinical trial

Regorafenib Monotherapy as Second-line Treatment of Patients With RAS-mutant Advanced Colorectal Cancer (STREAM)

Read time: 1 mins
Last updated:1st Nov 2015
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest